Standout Papers

Sunitinib versus Interferon Alfa in Metastatic Renal-Cell Carcinoma 2007 2026 2013 2019 4.4k
  1. Sunitinib versus Interferon Alfa in Metastatic Renal-Cell Carcinoma (2007)
    Robert J. Motzer, Thomas E. Hutson et al. New England Journal of Medicine
  2. Overall Survival and Updated Results for Sunitinib Compared With Interferon Alfa in Patients With Metastatic Renal Cell Carcinoma (2009)
    Robert J. Motzer, Thomas E. Hutson et al. Journal of Clinical Oncology
  3. PD 0332991, a selective cyclin D kinase 4/6 inhibitor, preferentially inhibits proliferation of luminal estrogen receptor-positive human breast cancer cell lines in vitro (2009)
    Richard S. Finn, Judy Dering et al. Breast Cancer Research
  4. A Clinically Relevant Androgen Receptor Mutation Confers Resistance to Second-Generation Antiandrogens Enzalutamide and ARN-509 (2013)
    James D. Joseph, Nhin Lu et al. Cancer Discovery

Immediate Impact

11 by Nobel laureates 8 from Science/Nature 137 standout
Sub-graph 1 of 13

Citing Papers

Overall Survival With Palbociclib Plus Letrozole in Advanced Breast Cancer
2024 Standout
Renal cell carcinoma
2024 Standout
34 intermediate papers

Works of Isan Chen being referenced

Overall Survival and Updated Results for Sunitinib Compared With Interferon Alfa in Patients With Metastatic Renal Cell Carcinoma
2023
Sunitinib versus Interferon Alfa in Metastatic Renal-Cell Carcinoma
2007 Standout
and 5 more

Author Peers

Author Last Decade Papers Cites
Isan Chen 6901 3565 4715 41 8.9k
Sindy T. Kim 8280 4491 5849 22 10.8k
Paul Bycott 4423 2909 3694 50 7.0k
Gary R. Hudes 6724 3485 6084 101 10.5k
Apurva A. Desai 3973 2426 3863 35 6.7k
Andrea Kay 4627 3189 3673 45 7.5k
Charles M. Baum 8095 4641 5831 70 12.6k
Claire Watkins 7692 7390 2865 41 10.8k
Tomasz Demkow 4227 2139 3567 76 6.5k
Minghua Shan 3946 2008 3313 38 5.9k
A Płużańska 8129 6183 3165 65 11.4k

All Works

Loading papers...

Rankless by CCL
2026